1. 3354 Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study. (September 2015) Authors: Urun, Y.; Abal, H.; Turna, H.; Esin, E.; Sedef, A.M.; Alkan, A.; Oksüzoğlu, B.; Ozdemir, N.Y.; Sendur, M.A.N.; Sezer, A.; Kiliçkap, S.; Akbulut, H.; Celik, I. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Single Center Analysis of Evolving Experience with ALPPS procedure: Towards Better Patient and Graft Selection. (2019) Authors: Balci, D.; Kirimker, E.O.; Ozcelik, M.; Ustuner, E.; Konca, C.; Utkan, G.; Akbulut, H.; Urun, Y.; Senler, F.C.; Demirkazik, A.; Gecim, E. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A single center analysis of evolving experience with ALPPS procedure: towards better patient and graft selection. (2019) Authors: Balci, D.; Kirimker, E.O.; Ozcelik, M.; Ustuner, E.; Konca, C.; Utkan, G.; Akbulut, H.; Urun, Y.; Senler, F.C.; Demirkazik, A.; Gecim, E. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗